Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Biocon Biologics Receives Further Investment As Value Hits $3.5bn
Tata Capital Takes 0.85% Holding
Jul 31 2020
•
By
Dean Rudge
Biocon has offloaded another sliver of equity in Biocon Biologics • Source: Shutterstock
More from Deals
More from Business